DNAKE Advances Brain-Computer Interface Technology
DNAKE (Xiamen) Intelligent Technology Co., Ltd. is making significant strides in Brain-Computer Interface (BCI) technology, focusing on healthcare and industrial applications, as announced in a press release. The company is leveraging strategic partnerships with elite research institutions to drive innovation and establish technical standards in the BCI field.
DNAKE's recent breakthroughs include the development of a "Human-AI Multi-agent Copilot" system, which combines EEG signal decoding with deep reinforcement learning AI. This system allows devices to interpret user commands while adapting to environmental changes, marking a shift from one-directional BCI systems to interactive intelligence. Additionally, DNAKE's research team has developed a Multiscale Temporal Convolutional Neural Network (MTCNN) algorithm that significantly improves sleep-stage classification accuracy.
With a dedicated $18 million BCI Technology Center and a substantial R&D team, DNAKE is committed to advancing BCI technology and expanding its influence in global markets. The company's focus on innovation and collaboration positions it as a key player in the rapidly growing BCI industry.
We hope you enjoyed this article
Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from Life Sciences
Sep 30 Insilico Medicine Selects AI Designed Obesity Drug Candidate ISM1354 Sep 29 Truven launches MarketScan Snapshot for healthcare data checks Sep 29 Omega Healthcare Wins Gold in 2026 AI Breakthrough Awards Sep 29 Phylo Launches Target Atlas for Drug Target Prioritization Sep 29 ChromAgeNet Detects Aging Signs in Blood Stem Cell ImagesLife AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
Industry analysis
2025 Global Business Services Agenda: Gen AI Takes Center Stage
This industry analysis by The Hackett Group explores the transformative impact of generative artificial intelligence (Gen AI) on global business services (GBS) in 2025. The study highlights the shift from exploration to acceleration of Gen AI initiatives, with 89% of executives advancing these projects to improve customer satisfaction, innovate products, and reduce costs. The report also discusses the challenges and strategies for successful Gen AI adoption, emphasizing the need for a technology-enabled operating model and the importance of reskilling the workforce.
Read moreYou may also like
Cellular Intelligence Adds Yann LeCun and Three Scientists to Advisory Board
Basecamp Research Raises $140 Million for AI Designed Therapeutics
Dreamdata Launches AI Analytics Tools for B2B Marketers
Brainomix Selected for UK Future Fifty Programme
Milliman MedInsight Introduces MIKE for Healthcare Analytics
Daily AI Brief: the AI news that matters, in your inbox.